REQUEST A DEMO
Total
USD $0.00
Search more companies

Ab Sciex Pte. Ltd. (Singapore)

Main Activities: Biological Product (except Diagnostic) Manufacturing
Full name: Ab Sciex Pte. Ltd. Profile Updated: March 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Ab Sciex Pte. Ltd. is a company based in Singapore, with its head office in Singapore. It operates in the Biological Product (except Diagnostic) Manufacturing sector. The company was established on August 03, 2009. In its most recent financial highlights, the company reported a net sales revenue increase of 8.84% in 2022. Its total assets grew by 4.69% over the same period. The net profit margin of Ab Sciex Pte. Ltd. increased by 0.09% in 2022.

Headquarters
33 Marsiling Ind Estate Road 3, #04-06, Singapore
Singapore; Singapore; Postal Code: 739256

Contact Details: Purchase the Ab Sciex Pte. Ltd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Ab Sciex Pte. Ltd. report to view the information.
Incorporation Date:
August 03, 2009
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Company Secretary
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Ab Sciex Pte. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
8.84%
Total operating revenue
8.84%
Net Profit (Loss) for the Period
9.21%
Total assets
4.69%
Total equity
13.86%
Net Profit Margin
0.09%
Return on Equity (ROE)
-0.52%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?